ATP2B2 and breast cancer: Consistent with the IHC data presented above, there were individual breast cancers with relative high levels of PMCA2 (ATP2B2) in all of the molecular subtypes (Fig. 2A), this was not seen for PMCA1 (ATP2B1) or PMCA4 (ATP2B4) (Fig. 2B,C).